Select for export Double-blind Placebo-controlled Naturalistic Study of Microdosing With Psilocybin: Effects on Brain Activity, Behavior, Cognition, Creativity, and Mental Health Abstract available at the source but not redistributed here. Read at source. Details Copy citation Copy BibTeX ClinicalTrials.gov 2021-12-15 National Council of Scientific and Technical Research, Argentina ClinicalTrials.gov CLINICAL TRIAL psilocybin Brain ImagingMechanism of ActionMicrodosing Other More
Select for export Announcement of two special issues: behavioural pharmacology of synaptopathies and psychedelic drugs Abstract available at the source but not redistributed here. Read at source. Details DOI 10.1097/fbp.0000000000000662 PubMed 35007231 Copy citation Copy BibTeX Behavioural Pharmacology 2021-12-12 Louk J. M. J. Vanderschuren, Paul Willner, Emily M. Jutkiewicz, Bart Ellenbroek OpenAlex Published psilocybin DepressionAnxietyPTSD Clinical Trial More
Select for export Microevidence for microdosing with psilocybin mushrooms: a double-blind placebo-controlled study of subjective effects, behavior, creativity, perception, cognition, and brain activity Abstract available at the source but not redistributed here. Read at source. Details DOI 10.1101/2021.11.30.470657 Copy citation Copy BibTeX bioRxiv 2021-12-06 Cavanna F, Muller S, de la Fuente LA, Zamberlan F, Palmucci M, Janeckova L bioRxiv PREPRINT (not peer reviewed) psilocybin Brain ImagingMicrodosingCreativity Other More
Select for export P.0553 Effect of chronic microdosing of psilocin on cell proliferation and behavior in rats No abstract availability was recorded for this entry. Details DOI 10.1016/j.euroneuro.2021.10.523 Copy citation Copy BibTeX European Neuropsychopharmacology 2021-11-30 Olejníková L., Danda H., Lhotková E., Kútná V., Šíchová K., Syrová K. Crossref Published psilocin Microdosing Other More
Select for export Microevidence for microdosing with psilocybin mushrooms: a double-blind placebo-controlled study of subjective effects, behavior, creativity, perception, cognition, and brain activity Abstract available at the source but not redistributed here. Read at source. Details DOI 10.5281/zenodo.5745892 Copy citation Copy BibTeX Zenodo (CERN European Organization for Nuclear Research) 2021-11-29 Enzo Tagliazucchi OpenAlex Published psilocybin Brain ImagingMicrodosingCreativity Other More
Select for export Psilocybin targets a common molecular mechanism for cognitive impairment and increased craving in alcoholism. Abstract available at the source but not redistributed here. Read at source. Details DOI 10.1126/sciadv.abh2399 PubMed 34788104 Copy citation Copy BibTeX Science Advances 2021-11-16 Meinhardt MW, Pfarr S, Fouquet G, Rohleder C, Meinhardt ML, Barroso-Flores J Europe PMC Published psilocybin Mechanism of ActionBiomarkers Other More
Select for export Human behavioral pharmacology of psychedelics. Abstract available at the source but not redistributed here. Read at source. Details DOI 10.1016/bs.apha.2021.10.003 PubMed 35341564 Copy citation Copy BibTeX Unknown journal 2021-11-10 Strickland JC, Johnson MW. Europe PMC Published psilocybin DepressionAddictionPharmacology Clinical Trial More
Select for export Case Report: Magic Mushroom (Psilocybe Cubensis) Intoxication Abstract available at the source but not redistributed here. Read at source. Details DOI 10.37275/amcr.v1i2.7 Copy citation Copy BibTeX Archives of The Medicine and Case Reports 2021-10-12 Andrian Fajar Kusumadewi OpenAlex Published psilocybin End-of-Life DistressChronic PainCase Report Case Report More
Select for export 6.2 OVERVIEW OF PSYCHEDELIC COMPOUNDS AND THEIR USE IN TREATMENT No abstract availability was recorded for this entry. Details DOI 10.1016/j.jaac.2021.07.052 Copy citation Copy BibTeX Journal of the American Academy of Child & Adolescent Psychiatry 2021-09-30 Matt T. Keener OpenAlex Published psilocybin Receptor Pharmacology Other More
Select for export Psychedelics, Sociality, and Human Evolution. Abstract available at the source but not redistributed here. Read at source. Details DOI 10.3389/fpsyg.2021.729425 PubMed 34659037 Copy citation Copy BibTeX Frontiers in Psychology 2021-09-28 Rodríguez Arce JM, Winkelman MJ. Europe PMC Published psilocybin Mechanism of ActionReceptor PharmacologyWellbeing Other More
Select for export Testing human hair after magic mushrooms abuse by LC-MS/MS: Pitfalls and limitations No abstract availability was recorded for this entry. Details DOI 10.1016/j.forc.2021.100364 Copy citation Copy BibTeX Forensic Chemistry 2021-09-19 Pascal Kintz, Jean-Sébastien Raul, Alice Ameline OpenAlex Published psilocybin PharmacologyReceptor PharmacologyToxicity Other More
Select for export New Insights Into the Clinical and Nonclinical Effects of Psychedelic Substances Abstract available at the source but not redistributed here. Read at source. Details DOI 10.1027/1016-9040/a000447 Copy citation Copy BibTeX European Psychologist 2021-09-16 Matthias Forstmann, Christina Sagioglou OpenAlex Published psilocybin DepressionAnxietyAddiction Review Article More
Select for export The therapeutical role of psychedelic drugs in treatment of mental disorders Abstract available at the source but not redistributed here. Read at source. Details DOI 10.36219/bpi.2021.3.09 Copy citation Copy BibTeX Bulletin of Integrative Psychiatry 2021-09-14 Dan Cătălin Oprea, Loretta Epure, Vasile Chiriță, Adrian Cantemir OpenAlex Published psilocybin DepressionAnxietyAddiction Other More
Select for export Is MDD the right target for early-stage psychedelic-assisted therapy trials? Abstract available at the source but not redistributed here. Read at source. Details DOI 10.1556/2054.2021.00180 Copy citation Copy BibTeX Journal of Psychedelic Studies 2021-09-14 Benjamin R. Lewis, Kevin Byrne OpenAlex Published psilocybin DepressionAnxietyReceptor Pharmacology Randomized Controlled Trial More
Select for export New Frontiers or a Bursting Bubble? Psychedelic Therapy Beyond the Dichotomy Abstract available at the source but not redistributed here. Read at source. Details DOI 10.3389/fpsyt.2021.727050 PubMed 34566724 Copy citation Copy BibTeX Frontiers in Psychiatry 2021-09-09 Tehseen Noorani, Jonny Martell OpenAlex Published psilocybin DepressionReceptor PharmacologyWellbeing Clinical Trial More
Select for export Treating Major Depression Disorder with Psychedelics: A Potential Therapeutic Application for Psilocybin? Abstract available at the source but not redistributed here. Read at source. Details DOI 10.51338/rppsm.2021.v7.i3.241 Copy citation Copy BibTeX Revista Portuguesa de Psiquiatria e Saúde Mental 2021-09-07 Gonçalo Cotovio, Ana Maia, Ana Velosa, Carolina Seybert, Albino J. Oliveira-Maia OpenAlex Published psilocybin DepressionReceptor Pharmacology Other More
Select for export A Complex Impact of Systemically Administered 5-HT2A Receptor Ligands on Conditioned Fear. Abstract available at the source but not redistributed here. Read at source. Details DOI 10.1093/ijnp/pyab040 PubMed 34228806 Copy citation Copy BibTeX The International Journal of Neuropsychopharmacology 2021-08-31 Hagsäter SM, Pettersson R, Pettersson C, Atanasovski D, Näslund J, Eriksson E. Europe PMC Published psilocybin AnxietyReceptor Pharmacology Other More
Select for export Psychedelics and Consciousness: Distinctions, Demarcations, and Opportunities. Abstract available at the source but not redistributed here. Read at source. Details DOI 10.1093/ijnp/pyab026 PubMed 33987652 Copy citation Copy BibTeX The international journal of neuropsychopharmacology 2021-08-19 Yaden DB, Johnson MW, Griffiths RR, Doss MK, Garcia-Romeu A, Nayak S PubMed Published psilocybin ConsciousnessReview Article Review Article More
Select for export Treating addiction with psychedelics - are we waking up? Abstract available at the source but not redistributed here. Read at source. Details Copy citation Copy BibTeX Unknown journal 2021-08-12 Miranda J, Barbosa M, Figueiredo I, Mota P, Tarelho A. Europe PMC Published psilocybin AddictionReceptor PharmacologyMystical Experience Review Article More
Select for export Safer Tripping: Serotonergic Psychedelics and Drug Checking. Submission and Detection Rates, Potential Harms, and Challenges for Drug Analysis Abstract available at the source but not redistributed here. Read at source. Details DOI 10.1007/s40429-021-00385-5 Copy citation Copy BibTeX Current Addiction Reports 2021-07-25 Tim Hirschfeld, Laura Smit-Rigter, Daan van der Gouwe, Simon Reiche, Heino Stöver, Tomislav Majić OpenAlex Published psilocybin End-of-Life DistressReceptor PharmacologyReview Article Review Article More
